Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    April 2017

  1. Correction: Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.
    Cancer Res. 2017;77:2174.
    PubMed     Text format    


  2. DRENBERG CD, Gibson AA, Pounds SB, Shi L, et al
    OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.
    Cancer Res. 2017;77:2102-2111.
    PubMed     Text format     Abstract available


    February 2017
  3. DE SMITH AJ, Kaur M, Gonseth S, Endicott AA, et al
    Correlates of prenatal and early-life tobacco smoke exposure and frequency of common gene deletions in childhood acute lymphoblastic leukemia.
    Cancer Res. 2017 Feb 15. pii: canres.2571.2016.
    PubMed     Text format     Abstract available


    January 2017
  4. TABE Y, Yamamoto S, Saitoh K, Sekihara K, et al
    Survival of acute monocytic leukemia cells is driven by fatty acid oxidation-mediated activation of AMPK in bone marrow adipocytes.
    Cancer Res. 2017 Jan 20. pii: canres.1645.2016.
    PubMed     Text format     Abstract available


  5. GAYMES TJ, Mohamedali A, Eiliazadeh A, Darling D, et al
    FLT3 and JAK2 mutations in acute myeloid leukemia promote inter-chromosomal homologous recombination and the potential for copy neutral loss of heterozygosity (CN-LOH).
    Cancer Res. 2017 Jan 20. pii: canres.1678.2016.
    PubMed     Text format     Abstract available


    December 2016
  6. SILVERBUSH D, Grosskurth S, Wang D, Powell F, et al
    Cell-specific computational modeling of the PIM pathway in acute myeloid leukemia.
    Cancer Res. 2016 Dec 13. pii: canres.1578.2016.
    PubMed     Text format     Abstract available


    November 2016
  7. ABDUL-AZIZ A, Shafat M, Mehta T, Di Palma F, et al
    MIF-induced stromal PKCbeta/IL8 is essential in human acute myeloid leukemia.
    Cancer Res. 2016 Nov 21. pii: canres.1095.2016.
    PubMed     Text format     Abstract available


  8. DING L, Sun QY, Tan KT, Chien W, et al
    Mutational landscape of pediatric acute lymphoblastic leukemia.
    Cancer Res. 2016 Nov 21. pii: canres.1303.2016.
    PubMed     Text format     Abstract available


  9. WEI TW, Wu PY, Wu TJ, Hou HA, et al
    Aurora A and NF-kappaB Survival Pathway Drive Chemoresistance in Acute Myeloid Leukemia via the TRAF-Interacting Protein TIFA.
    Cancer Res. 2016 Nov 10. doi: 10.1158/0008-5472.CAN-16-1004.
    PubMed     Text format     Abstract available


    October 2016
  10. DUQUE-AFONSO J, Lin CH, Han K, Wei MC, et al
    E2A-PBX1 remodels oncogenic signaling networks in B-cell precursor acute lymphoid leukemia.
    Cancer Res. 2016 Oct 7. pii: canres.1899.2016.
    PubMed     Text format     Abstract available


  11. ZHENG X, Fan X, Fu B, Zheng M, et al
    EpCAM inhibition sensitizes chemoresistant leukemia to immune surveillance.
    Cancer Res. 2016 Oct 3. pii: canres.0842.2016.
    PubMed     Text format     Abstract available


    September 2016
  12. LI JM, Petersen CT, Li J, Panjwani R, et al
    Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Vasoactive Intestinal Peptide.
    Cancer Res. 2016 Sep 26. pii: canres.0427.2016.
    PubMed     Text format     Abstract available


  13. TRAER E, Martinez J, Javidi-Sharifi N, Agarwal A, et al
    FGF2 from marrow microenvironment promotes resistance to FLT3 inhibitors in acute myeloid leukemia.
    Cancer Res. 2016 Sep 26. pii: canres.3569.2016.
    PubMed     Text format     Abstract available



  14. Correction: An IkappaB alpha Inhibitor Causes Leukemia Cell Death through a p38 MAP Kinase-dependent, NF-kappaB-independent Mechanism.
    Cancer Res. 2016;76:5584.
    PubMed     Text format    


  15. SAMUEL J, Jayne S, Chen Y, Majid A, et al
    Posttranscriptional upregulation of p53 by reactive oxygen species in chronic lymphocytic leukemia.
    Cancer Res. 2016 Sep 7. pii: canres.0843.2016.
    PubMed     Text format     Abstract available


    August 2016
  16. GATJEN M, Brand F, Grau M, Gerlach K, et al
    Splenic marginal zone granulocytes acquire an accentuated neutrophil B cell-helper phenotype in chronic lymphocytic leukemia.
    Cancer Res. 2016 Aug 3. pii: canres.3486.2015.
    PubMed     Text format     Abstract available


    June 2016
  17. RICHMOND J, Robbins A, Evans K, Beck D, et al
    Acute sensitivity of Ph-like acute lymphoblastic leukemia to the SMAC-mimetic birinapant.
    Cancer Res. 2016 Jun 14. pii: canres.0523.2016.
    PubMed     Text format     Abstract available


  18. BACHEGOWDA L, Morrone K, Winski SL, Mantzaris I, et al
    Pexmetinib: a novel dual inhibitor of Tie-2 and p38 MAPK with efficacy in preclinical models of myelodysplastic syndromes and acute myeloid leukemia.
    Cancer Res. 2016 Jun 10. pii: canres.3062.2015.
    PubMed     Text format     Abstract available


  19. JIANG X, Bugno J, Hu C, Yang Y, et al
    Eradication of acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles.
    Cancer Res. 2016 Jun 8. pii: canres.2949.2015.
    PubMed     Text format     Abstract available


    May 2016
  20. KOTHARI A, Hittelman WN, Chambers TC
    Cell cycle-dependent mechanisms underlie vincristine-induced death of primary acute lymphoblastic leukemia cells.
    Cancer Res. 2016 May 6. pii: canres.2104.2015.
    PubMed     Text format     Abstract available



  21. Correction: Aberrant Notch Signaling in the Bone Marrow Microenvironment of Acute Lymphoid Leukemia Suppresses Osteoblast-Mediated Support of Hematopoietic Niche Function.
    Cancer Res. 2016;76:2847.
    PubMed     Text format    


  22. SANDRI S, Bobisse S, Moxley K, Lamolinara A, et al
    Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.
    Cancer Res. 2016;76:2540-2551.
    PubMed     Text format     Abstract available


    March 2016
  23. YU ZY, Xiao H, Wang LM, Shen X, et al
    Natural product vibsanine A induces differentiation of myeloid leukemia cells through PKC activation.
    Cancer Res. 2016 Mar 16. pii: canres.1616.2015.
    PubMed     Text format     Abstract available


  24. FREIREICH E
    Commentary on Thomas and Epstein: "Bone Marrow Transplantation in Acute Leukemia".
    Cancer Res. 2016;76:1301-2.
    PubMed     Text format    


  25. CONERY AR, Centore RC, Spillane KL, Follmer NE, et al
    Preclinical Anticancer Efficacy of BET Bromodomain Inhibitors Is Determined by the Apoptotic Response.
    Cancer Res. 2016;76:1313-9.
    PubMed     Text format     Abstract available


  26. JOHNSON N, De Ieso P, Migliorini G, Orr N, et al
    Cytochrome P450 Allele CYP3A7*1C Associates with Adverse Outcomes in Chronic Lymphocytic Leukemia, Breast, and Lung Cancer.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  27. GUPTA K, Stefan T, Ignatz-Hoover J, Moreton S, et al
    GSK-3 inhibition sensitizes acute myeloid leukemia cells to 1,25D-mediated differentiation.
    Cancer Res. 2016 Mar 10. pii: canres.2290.2015.
    PubMed     Text format     Abstract available


  28. GRIESSINGER E, Anjos-Afonso F, Vargaftig J, Taussig D, et al
    Frequency and dynamics of leukemia-initiating cells during short-term ex vivo culture informs outcomes in acute myeloid leukemia patients.
    Cancer Res. 2016 Mar 9. pii: canres.2063.2015.
    PubMed     Text format     Abstract available


  29. DOLAI S, Sia KC, Robbins AK, Zhong L, et al
    Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia.
    Cancer Res. 2016 Mar 9. pii: canres.2786.2015.
    PubMed     Text format     Abstract available


  30. FARRAR JE, Schuback HL, Ries RE, Wai D, et al
    Genomic profiling of pediatric acute myeloid leukemia reveals a changing mutational landscape from disease diagnosis to relapse.
    Cancer Res. 2016 Mar 3. pii: canres.1015.2015.
    PubMed     Text format     Abstract available


  31. CLARKSON BD
    Commentary on Sandberg et al., "The In Vivo Chromosome Constitution of Marrow".
    Cancer Res. 2016;76:991-3.
    PubMed     Text format    


    February 2016
  32. GUO Y, Updegraff BL, Park S, Durakoglugil D, et al
    Comprehensive Ex Vivo Transposon Mutagenesis Identifies Genes That Promote Growth Factor Independence and Leukemogenesis.
    Cancer Res. 2016;76:773-86.
    PubMed     Text format     Abstract available


  33. KRENN PW, Hofbauer SW, Pucher S, Hutterer E, et al
    ILK induction in lymphoid organs by a TNFalpha-NF-kappaB-regulated pathway promotes the development of chronic lymphocytic leukemia.
    Cancer Res. 2016 Feb 2. pii: canres.3379.2015.
    PubMed     Text format     Abstract available


  34. MCGRATH JP, Williamson KE, Balasubramanian S, Odate S, et al
    Pharmacological inhibition of the histone lysine demethylase KDM1A suppresses the growth of multiple acute myeloid leukemia subtypes.
    Cancer Res. 2016 Feb 2. pii: canres.2333.2015.
    PubMed     Text format     Abstract available


  35. PRIETO C, Stam RW, Agraz-Doblas A, Ballerini P, et al
    Activated KRAS cooperates with MLLAF4 to promote extramedullary engraftment and migration of cord blood CD34+ HSPC but is insufficient to initiate leukemia.
    Cancer Res. 2016 Feb 2. pii: canres.2769.2015.
    PubMed     Text format     Abstract available


  36. CHEN WC, Yuan JS, Xing Y, Mitchell A, et al
    An integrated analysis of heterogeneous drug responses in acute myeloid leukemia that enables the discovery of predictive biomarkers.
    Cancer Res. 2016 Feb 1. pii: canres.2743.2015.
    PubMed     Text format     Abstract available


  37. LI Z, Chen P, Su R, Hu C, et al
    PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
    Cancer Res. 2016;76:619-29.
    PubMed     Text format     Abstract available


    January 2016
  38. ZHANG W, Borthakur G, Gao C, Chen Y, et al
    The dual MEK/FLT3 inhibitor E6201 exerts cytotoxic activity against acute myeloid leukemia cells harboring resistance-conferring FLT3 mutations.
    Cancer Res. 2016 Jan 28. pii: canres.1580.2015.
    PubMed     Text format     Abstract available


  39. WANG W, Zimmerman G, Huang X, Yu S, et al
    Aberrant Notch signaling in the bone marrow microenvironment of acute lymphoid leukemia suppresses osteoblast-mediated support of hematopoietic niche function.
    Cancer Res. 2016 Jan 22. pii: canres.2092.2015.
    PubMed     Text format     Abstract available


    December 2015
  40. MAXSON JE, Abel ML, Wang J, Deng X, et al
    Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.
    Cancer Res. 2015.
    PubMed     Text format     Abstract available



  41. Correction: CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy.
    Cancer Res. 2015;75:5167.
    PubMed     Text format    


  42. BAKER A, Gregory G, Verbrugge I, Kats L, et al
    The CDK9 inhibitor dinaciclib exerts potent apoptotic and antitumor effects in preclinical models of MLL-rearranged acute myeloid leukemia.
    Cancer Res. 2015 Dec 1. pii: canres.1070.2015.
    PubMed     Text format     Abstract available


    October 2015
  43. MITOBE Y, Yasunaga J, Furuta R, Matsuoka M, et al
    HTLV-1 bZIP Factor RNA and Protein Impart Distinct Functions on T-cell Proliferation and Survival.
    Cancer Res. 2015;75:4143-52.
    PubMed     Text format     Abstract available


  44. CAPUANO C, Romanelli M, Pighi C, Cimino G, et al
    Anti-CD20 Therapy Acts via FcgammaRIIIA to Diminish Responsiveness of Human Natural Killer Cells.
    Cancer Res. 2015;75:4097-108.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: